WT1 and neoplasm: It has been speculated that DSRCTs are derived from mesothelial or submesothelial cells because a vast majority of patients develop DSRCTs in cavities that are lined with mesothelial cells or because tumor cells show immunohistochemical positivity for epithelial and mesenchymal antigens including desmin, and WT-1 [12].